adalimumab-adbm

CHEBI:CHEBI_749460

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_strength
40 mg/.8mL
rxcui
2640898
spl_set_id
62f39a7c-00df-4519-a8d4-39bbd0a649ed
active_ingredient_name
ADALIMUMAB-ADBM
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
dosage_form
INJECTION, SOLUTION
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
marketing_category
DRUG FOR FURTHER PROCESSING
marketing_start_date
20231001
package_marketing_start_date
01-JUL-23
labeler_name
Catalent Indiana, LLC
manufacturer_name
QUALLENT PHARMACEUTICALS HEALTH LLC
brand_name
Adalimumab-adbm
brand_name_base
Adalimumab-adbm
generic_name
Adalimumab-adbm
product_ndc
0597-0405
application_number
BLA761058
spl_id
34634356-62a0-4e45-9302-b3c00c80fe72
package_ndc
0597-0405-80
package_description
2 KIT in 1 CARTON (0597-0405-80) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET